Avodart Capsule 0.5mg (Dutasteride) x30

Avodart Capsule 0.5mg contains Dutasteride, a 5-alpha reductase inhibitor used to treat benign prostatic hyperplasia (BPH) in men. This medication reduces prostate size and improves urinary symptoms associated with enlarged prostate.

Uses

Avodart treats moderate to severe symptoms of benign prostatic hyperplasia (enlarged prostate) in men. It reduces the risk of acute urinary retention and decreases the need for BPH-related surgery. Avodart is also used off-label for male pattern baldness treatment.

Benefits

• Reduces prostate size significantly over time
• Improves urinary flow and reduces symptoms
• Decreases risk of acute urinary retention
• Reduces need for prostate surgery
• Provides long-term symptom relief
• May help with male pattern hair loss
• Once-daily convenient dosing
• Effective for long-term prostate management
• Reduces BPH progression

How It Works

Avodart inhibits both Type I and Type II 5-alpha reductase enzymes, preventing conversion of testosterone to dihydrotestosterone (DHT). By reducing DHT levels, the medication causes gradual prostate shrinkage and improves urinary symptoms over several months of treatment.

Dosage

Take Avodart capsules whole with water, with or without food. Do not crush, chew, or open capsules.

Duration of Action

Avodart has a very long half-life, remaining in the system for several months after discontinuation. Initial improvements in urinary symptoms may be noticed within 3-6 months, with maximum benefits typically achieved after 6-12 months of continuous treatment.

Side Effects

Common side effects include decreased libido, erectile dysfunction, and ejaculation disorders. Some men experience breast tenderness or enlargement. These sexual side effects may persist even after discontinuing treatment in some patients. Allergic reactions are rare but possible.

Warning

Avodart can be absorbed through skin contact and may harm pregnant women or developing male fetuses. Women of childbearing age should avoid handling leaking capsules. The medication may increase risk of high-grade prostate cancer. Regular prostate examinations are recommended during treatment.

Pregnancy and Breastfeeding

Avodart is contraindicated for use by women. Pregnant women must avoid contact with leaking capsules as dutasteride can cause birth defects in male fetuses. Men taking Avodart should not donate blood during treatment and for 6 months after discontinuation.

Interaction

• May interact with certain HIV protease inhibitors
• Possible interactions with some antifungal medications
• Could affect PSA test results, requiring dose adjustment
• May interact with alpha-blockers when used together
• Potential interactions with some calcium channel blockers

Precaution

Regular prostate examinations and PSA monitoring are essential during treatment. Use caution in patients with liver disease as dutasteride is metabolized hepatically. Inform all healthcare providers about Avodart use before any procedures. Handle capsules carefully to avoid skin contact with contents.

Important Information

Avodart requires several months to show full effectiveness for BPH symptoms. PSA levels typically decrease by about 50% after 6 months of treatment. Do not donate blood while taking Avodart and for 6 months after stopping. Store capsules at room temperature and protect from light and moisture. Women and children should avoid contact with this medication.